NSTS vs RARE · rev $252.0K vs rev $350.0M
NSTS Bancorp Inc (NSTS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
NSTS Bancorp Inc (NSTS) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NSTS revenue for 2025-12-31 was $252.0K. Net income was -$386.0K. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. NSTS currently screens at market cap $63.0M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
NSTS currently screens at market cap $63.0M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NSTS and RARE stock pages for the full models.
Not investment advice.